CYTED
LIVE

Serial Number

79312452

Owner

Cyted Ltd

Attorney

Michael R. Friscia

Filing Date

Mar 22, 2021

Add to watchlist:

No watchlists yet
View on USPTO

CYTED Trademark

Serial Number: 79312452 • Registration: 7014495

CYTED is a trademark filed by Cyted Ltd on March 22, 2021. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Cyted Ltd (2 trademarks)

22 Station Road

Entity Type: 99

Trademark Details

Filing Date

March 22, 2021

Registration Date

April 4, 2023

Published for Opposition

January 17, 2023

Goods & Services

Downloadable computer software for cancer and gastrointestinal disease screening and diagnostic purposes for use in medical decision support systems

Medical services; medical testing, screening and diagnostic services for cancer and gastrointestinal disease; medical diagnostic testing, monitoring and reporting services; medical testing for diagnostic or treatment purposes; medical testing services relating to the diagnosis and treatment of disease; medical advisory services; medical treatment services, for pathology; arranging of medical treatment, namely, providing medical diagnostic testing, monitoring and reporting services for pathology in the field of cancer and gastrointestinal disease; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; performing diagnosis of diseases; medical services for the diagnosis of conditions of the human body; medical analysis services for cancer and gastrointestinal disease, namely, screening and diagnostics; medical examination of individuals; medical and healthcare clinics being facilities with access for patients; providing medical information regarding testing and diagnosis of diseases and infections; providing medical information regarding diagnosis and treatment of diseases and infections; medical analysis services for cancer diagnosis and prognosis; medical analysis services relating to the treatment of patients and persons; medical analysis services, for screening and diagnostic purposes provided by medical laboratories; medical laboratory services for the analysis of samples taken from patients; medical services relating to the removal, treatment and processing of human cells; computer aided medical diagnostic testing services

Diagnostic imaging apparatus for medical use; diagnostic testing apparatus for use in medical immunoassay procedures; diagnostic testing apparatus for use in medical molecular analyses; diagnostic, examination, and monitoring equipment for medical use and pathology, namely, for cancer and gastrointestinal disease; diagnostic instruments for medical use for pathology for detecting cancer and gastrointestinal disease; diagnostic measuring apparatus for medical use and pathology, namely, for cancer and gastrointestinal disease; medical diagnostic apparatus for medical purposes and pathology, namely, for cancer and gastrointestinal disease; medical diagnostic instruments for medical use for pathology, namely, for cancer and gastrointestinal disease

Medical laboratories; medical and pharmacological research services; medical laboratory services; medical research; medical research laboratory services; medical research services; software as a service (SaaS) services featuring software for identifying markers for screening and diagnostic purposes for cancer and gastrointestinal disease; software creation; software customisation services; software design; software design and development; biomedical research services; design and development of medical technology; design and development of computer software for use with medical technology; platforms for artificial intelligence as software as a service (SaaS), namely, software as a service (SaaS) services featuring software for identifying markers for screening and diagnostic purposes for cancer and gastrointestinal disease; database design and development; design and development of computer database programs and software; design and development of computer software for use with medical technology, logistics, reading data, supply chain management; design and development of computer software architecture; design and development of data display entry and output systems, data processing apparatus, programmes, software and systems; design and development of diagnostic apparatus

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 14, 2023 FINO
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jul 23, 2023 ADCH
FINAL DISPOSITION NOTICE SENT TO IB
Jul 20, 2023 FICS
FINAL DISPOSITION PROCESSED
Jul 20, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 4, 2023 FICR
NEW REPRESENTATIVE AT IB RECEIVED
Apr 21, 2023 NREP
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 4, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 4, 2023 R.PR
NOTIFICATION PROCESSED BY IB
Jan 24, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 17, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jan 17, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 4, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 4, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 28, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 12, 2022 CNSA
ATTORNEY REVIEW COMPLETED
Dec 12, 2022 ATRV
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Nov 27, 2022 OPNX
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Nov 23, 2022 ERFR
EX PARTE APPEAL-INSTITUTED
Nov 23, 2022 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Nov 23, 2022 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Nov 23, 2022 EXAF
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 9, 2022 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Nov 9, 2022 OPNR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jun 6, 2022 GNFN
FINAL REFUSAL E-MAILED
Jun 6, 2022 GNFR
FINAL REFUSAL WRITTEN
Jun 6, 2022 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 31, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 31, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 31, 2022 TROA
REFUSAL PROCESSED BY IB
Dec 19, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 29, 2021 RFCS
REFUSAL PROCESSED BY MPU
Nov 29, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 28, 2021 RFCR
NON-FINAL ACTION WRITTEN
Oct 27, 2021 CNRT
ASSIGNED TO EXAMINER
Oct 26, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 11, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 7, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 3, 2021 REPR